Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group trials.

Flaherty, L E; Atkins, M; Sosman, J; Weiss, G; Clark, J I; Margolin, K; Dutcher, J; Gordon, M S; Lotze, M; Mier, J; Sorokin, P; Fisher, R I; Appel, C; Du, W

Flaherty, L E; Atkins, M; Sosman, J; Weiss, G; Clark, J I; Margolin, K; Dutcher, J; Gordon, M S; Lotze, M; Mier, J; Sorokin, P; Fisher, R I; Appel, C; Du, W.

Affiliation

Flaherty LE; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA. flaherty@karmanos.org

J Clin Oncol ; 19(13): 3194-202, 2001 Jul 01.

Article in En | MEDLINE | ID: mdl-11432886

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Interleukin-2 / Interferon-alpha / Melanoma Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2001 Document type: Article Affiliation country: Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links